![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Open Price
2.50Prev. Close
2.2600Volume
4331.00Value
10827.50Market Cap
11.90
Price to Earnings
-397.50
Price to Book Value
18.70
Dividend Yield
0.00
PE to Growth
0.40
Op Revenue TTM
0.19
Net Profit TTM
-0.03
Cash From Operating Activity
0.00
Return on Equity %
-4.68
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
05 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
2.58
Second Resistance
2.65
Third Resistance
2.70
First Support
2.46
Second Support
2.41
Third Support
2.34
Relative Strength Index
60.05
Money Flow Index
77.32
MACD
0.06
MACD Signal
0.04
Average True Range
0.13
Average Directional Index
15.21
Rate of Change (21)
15.74
Rate of Change (125)
26.9
Commodity Channel Index
169.6
Williams %R
-27.9
BETA
1 Month
-0.05
3 Month
-0.04
1 Year
0.16
3 Year
PRICE CHANGE ANALYSIS
1 Week
Low
High
2.31
2.62
1 Month
Low
High
2.03
2.62
3 Months
Low
High
1.95
2.62
6 Months
Low
High
1.41
2.62
1 Year
Low
High
1.41
2.8
Kashyap Tele-Medicines Ltd - 531960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2024Kashyap Tele-Medicines Ltd - 531960 - Closure of Trading Window
Closure of Trading Window for quarter ended 30th June, 2024Kashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication-Financial ResultsKashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Independent DirectorKashyap Tele-Medicines Ltd - 531960 - Announcement under Regulation 30 (LODR)-Change in Management
Re-appointment of Independent Director, Internal Auditor and Secretarial AuditorKashyap Tele-Medicines Ltd - 531960 - Results-Financial Results For Quarter And Year Ended 31St March, 2024
Submission of financial results for quarter and year ended 31st, March, 2024Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board meeting held on 17th May, 2024Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Intimation For Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve the audited financial results for the quarter and financial year ended on 31st March 2024 and Audit Report thereon and to consider and approve the audited financial statement for the year ended on 31st March 2024 and Audit Report thereon;Kashyap Tele-Medicines Ltd - 531960 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Non-Applicability of Annual Secretarial Compliance Report for year ended 31st March, 2024Kashyap Tele-Medicines Ltd - 531960 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKashyap Tele-Medicines Ltd 2CIN NO.L29110MH1995PLC085738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: JYOTI SAHU Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Raghav Agrawal Designation: Director and Chief Financial Officer EmailId: [email protected] Date: 20/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.The latest market price of Kashyap Tele-Medicines Ltd. on NSE was Rs. 2.50 as of today.
The opening share price of Kashyap Tele-Medicines Ltd. was Rs. 2.50 as of today.
The 52-week high share price of Kashyap Tele-Medicines Ltd. was Rs. 2.80.
The 52 week low share price of Kashyap Tele-Medicines Ltd. was Rs. 1.40.
The PE ratio of Kashyap Tele-Medicines Ltd. is 0.40. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest split issue declared by Kashyap Tele-Medicines Ltd. was as of 2001-04-30. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Kashyap Tele-Medicines Ltd..